Urovant Sciences® Named 17th on the List of Fortune® Best Workplaces in BioPharma™ (2022)

Urovant Sciences, Inc. receives Fortune and Great Place to Work Best Workplaces in BioPharma (2022) recognition. Follows Urovant’s Best Place to Work recognition by the Orange County Business Journal for the second year in a row, along with becoming a Great Place to Work-Certified™ company earlier this year. The Best Workplaces in BioPharma award is … [Read more…]

epocrates Launches Bugs + Drugs Tool to Promote Optimal Antibiotic Prescribing Amid Healthcare’s Growing Antimicrobial Resistance Crisis

Only solution of its kind in the ambulatory setting offers information on localized antibiotic susceptibility patterns and associated drug information WATERTOWN, Mass.–(BUSINESS WIRE)–epocrates, an athenahealth, Inc. company that delivers digital clinical decision support to healthcare professionals, today announced the release of Bugs + Drugs, a mobile tool that offers clinicians information about bacteria types and … [Read more…]

Medical Properties Trust Announces Successful Operator Transition at Watsonville Community Hospital and Sale of 11 Facilities to Prime Healthcare

Approximately $600 Million of Incremental Liquidity Expected, Inclusive of Proceeds from Anticipated Springstone Operating Loan Repayment Transactions Highlight Enduring Demand for Essential Hospital Real Estate BIRMINGHAM, Ala.–(BUSINESS WIRE)–Medical Properties Trust, Inc. (the “Company” or “MPT”) (NYSE: MPW) today announced that it has successfully re-leased its Watsonville Community Hospital in Watsonville, CA to Pajaro Valley Health … [Read more…]

BostonGene Announces Strategic Alliance with the Massachusetts General Hospital Cancer Center

WALTHAM, Mass.–(BUSINESS WIRE)–BostonGene Corporation today announced a Master Agreement with Massachusetts General Hospital Cancer Center, a member of the Mass General Brigham (MGB) healthcare system, to collaborate on multiple research projects. The alliance aims to support clinical research utilizing BostonGene’s CLIA-certified and CAP-accredited high complexity molecular laboratory and advanced computational algorithms to identify and validate … [Read more…]

Medidata Experts to Discuss the Evolution of Clinical Data Management at SCDM Annual Conference

Company Innovators to Lead Sessions on Regulatory Affairs, Imaging, Risk-Based Quality Management, and Medidata Clinical Cloud Technology NEW YORK–(BUSINESS WIRE)–Experts from Medidata, a Dassault Systèmes company, will be chairing sessions on promoting consensus between regulators and the industry, imaging quality control, and presenting a product showcase on Medidata Clinical Cloud at the Society for Clinical … [Read more…]

First Patient Enrolled in AMIHOT III Trial Investigating ZOLL’s Supersaturated Oxygen Therapy in Heart Attack Patients

Study Evaluates the Effectiveness of TherOx Supersaturated Oxygen (SSO2) Therapy in Patients Presenting with Acute Anterior Myocardial Infarction with Successful Reperfusion Compared to Standard Therapy CHELMSFORD, Mass.–(BUSINESS WIRE)–ZOLL® Medical Corporation, an Asahi Kasei company that manufactures medical devices and related software solutions, announced today that the first patient has enrolled in the AMIHOT III post-approval … [Read more…]

BCV Announces First-In-Human Cases with GECKO System Aimed at Increased Procedural Speed and Reduced Complication in Neurovascular Procedures

REIMS, France–(BUSINESS WIRE)–BCV announces a major step in the development and evaluation of steerable mechatronic guidewires for stroke treatment – the GECKO System. The first-in-human case was conducted by Michel Piotin, MD, PhD, head of Interventional neuroradiology at Foundation Rothschild Hospital in Paris, France. Worldwide each year more than 12.2 million people suffer a stroke.1 … [Read more…]

Arpeggio Biosciences Raises $17 Million in Series A Funding Led by Builders VC

New capital will support ongoing development of their drug pipeline targeting transcriptional mechanisms in disease Arpeggio’s technology isolates a drug’s effect on entire transcriptomes and has identified new modulators of hard-to-drug proteins like transcription factors To date, Arpeggio has contracted with more than 40 pharmaceutical companies to assess the impact of diverse classes of molecules … [Read more…]

Exscientia to Present at Upcoming Investor Conferences in September

OXFORD, England–(BUSINESS WIRE)–Exscientia (Nasdaq: EXAI) today announced that Company management will participate in the following investor conferences in September: Morgan Stanley Annual Global Healthcare Conference: Date: Wednesday, September 14, 2022 Time: 3:35 p.m. BST / 10:35 a.m. EST Location: New York, New York Participants: Ben Taylor, CFO & Chief Strategy Officer and Dave Hallett, Chief … [Read more…]

CONNECT1 Study Published in Journal of Allergy and Clinical Immunology: In Practice Evaluates the Potential of ProAir® Digihaler® (albuterol sulfate) Inhalation Powder and Digihaler System to Help Improve Asthma Management

Results from the study showed adults and children aged 13 and older with uncontrolled asthma using the ProAir Digihaler and its integrated system had 85.3% higher odds of improving their asthma control after three months compared with those using standard of care albuterol inhalers Physicians reported more interactions with patients on poor inhaler technique based … [Read more…]